Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis.
Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis.
复制标题
结核病的联合药物治疗。
DOI:
10.1172/jci103912
复制
发表时间:
1959
期刊:
影响因子:
--
通讯作者:
G. Middlebrook
中科院分区:
文献类型:
--
作者:
W. Russell;I. Kass;A. Heaton;S. Dressler;G. Middlebrook
Microbiologic investigation of the prevention of emergence of mutant populations of tubercle bacilli resistant to streptomycin and isoniazid emphasized the fact that adequate concentrations of each of these two appropriate drugs were necessary (1). Delivery of such concentrations of isoniazid to the multiplying parasites can be estimated by microbiologic assay (2-4). Antimicrobially-active serum streptomycin assayed by a similar microbiologic method confirmed that there were also probably significant variations between in-dividuals inserum levels of this drug as well. These observations suggested that conventional dosages of these drugs could not be relied upon to insure the delivery in vivo of sterilizing concentrations of each agent to physiologically-suscepti-ble tubercle bacilli. The result of consideration of these principles was the formulation of a chemo-therapeutic regimen combining high dosage of streptomycin with high dosage of isoniazid for all patients (5-7). The purpose of this report (the third of a series) is to presentthe results of clinical application of this approach to chemotherapy of pulmonary tuberculosis.